View Section: Eyestock Rating
Gene Fair Value
CR
CRXM stock is not valued by Eyestock.
The company does not have a valuation due to the unstable frequency of reports
Discover Undervalued Companies
Gene Valuation
Price chart is not available
1y
3y
5y
All time
Market price
Current market price
Fair value
Min value
Max value
22.12.2024
Market price:
* Eyestock is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on eyestock.io represent a recommendation to buy or sell a security.
Gene Biotherapeutics Inc price metrics
-91.8
Annual return (geometric mean)
823.26
Risk (standard deviation) of returns
β
22.76
Beta (volatility compared to market)
It means that CRXM stock is more volatile than the broader market
View Section: Profitability